Pages that link to "Q38316939"

The following pages link to A mouse model for spinal muscular atrophy (Q38316939):

Displaying 50 items.

• PRTFDC1 Is a Genetic Modifier of HPRT-Deficiency in the Mouse (Q21135297) (← links)
• Modeling spinal muscular atrophy in Drosophila (Q21562542) (← links)
• Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein (Q24291073) (← links)
• SMN interacts with a novel family of hnRNP and spliceosomal proteins (Q24535803) (← links)
• Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein (Q24600358) (← links)
• The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy (Q24604444) (← links)
• Analysis of human small nucleolar RNAs (snoRNA) and the development of snoRNA modulator of gene expression vectors (Q24630878) (← links)
• A positive modifier of spinal muscular atrophy in the SMN2 gene (Q24646149) (← links)
• The RNA binding protein hnRNP Q modulates the utilization of exon 7 in the survival motor neuron 2 (SMN2) gene (Q24648050) (← links)
• Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition (Q24655533) (← links)
• A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice (Q24657021) (← links)
• A functional interaction between the survival motor neuron complex and RNA polymerase II (Q24674951) (← links)
• Opening the window: The case for carrier and perinatal screening for spinal muscular atrophy (Q26741506) (← links)
• Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases (Q26750803) (← links)
• Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy (Q26752798) (← links)
• Spinal muscular atrophy: from gene discovery to clinical trials (Q26824894) (← links)
• Spinal muscular atrophy: development and implementation of potential treatments (Q26861377) (← links)
• Splicing therapy for neuromuscular disease (Q27009581) (← links)
• High expression level of Tra2-β1 is responsible for increased SMN2 exon 7 inclusion in the testis of SMA mice (Q27311317) (← links)
• Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA) (Q27312220) (← links)
• The spinal muscular atrophy disease protein SMN is linked to the Golgi network (Q27329644) (← links)
• A large animal model of spinal muscular atrophy and correction of phenotype (Q27340106) (← links)
• Exclusion of Htra2-beta1, an up-regulator of full-length SMN2 transcript, as a modifying gene for spinal muscular atrophy (Q28142479) (← links)
• An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA (Q28204816) (← links)
• Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1 (Q28206060) (← links)
• The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1 (Q28213183) (← links)
• The protective effects of beta-lactam antibiotics in motor neuron disorders (Q28241331) (← links)
• The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells (Q28242279) (← links)
• A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy (Q28244480) (← links)
• Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts (Q28261807) (← links)
• Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response (Q28266165) (← links)
• SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy (Q28271235) (← links)
• Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy (Q28279022) (← links)
• Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery (Q28288188) (← links)
• Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice (Q28288250) (← links)
• Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition (Q28288824) (← links)
• Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy (Q28301395) (← links)
• Spinal muscular atrophy: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence (Q28302547) (← links)
• Regulation of SMN protein stability (Q28304878) (← links)
• A comparison of three electrophysiological methods for the assessment of disease status in a mild spinal muscular atrophy mouse model (Q28544408) (← links)
• Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides (Q28551647) (← links)
• Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons (Q28576647) (← links)
• The critical role of membralin in postnatal motor neuron survival and disease (Q28585103) (← links)
• Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides (Q28818017) (← links)
• SMN in spinal muscular atrophy and snRNP biogenesis (Q29013847) (← links)
• Induced pluripotent stem cells from a spinal muscular atrophy patient (Q29614340) (← links)
• Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo (Q30486481) (← links)
• A novel method for oral delivery of drug compounds to the neonatal SMNDelta7 mouse model of spinal muscular atrophy (Q30488346) (← links)
• Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy (Q30492560) (← links)
• Sodium vanadate combined with L-ascorbic acid delays disease progression, enhances motor performance, and ameliorates muscle atrophy and weakness in mice with spinal muscular atrophy. (Q30540653) (← links)